Condition: CYP2C19 Genetic Variants · Sponsor: Stanford University
The investigators will examine whether a non-invasive screening tool for CYP2C19 genetic variants can be developed by measuring limonene metabolism.
This description comes directly from the study's public registry record.
Eric Gross, MD/PhD · (650)721-4521 · ergross@stanford.edu
Always discuss trial participation with your own doctor first.
| Stanford School of Medicine | Stanford, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05078723